Administration of Tadalafil in Patients With Benign Prostatic Hyperplasia
Phase 3
Completed
- Conditions
- BPH With Other Lower Urinary Tract Symptoms
- Registration Number
- NCT06466369
- Lead Sponsor
- Al-Azhar University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Male
- Target Recruitment
- Not specified
Inclusion Criteria
Inclusion Criteria:<br><br> - Aged = 45 years and sexually active with symptomatic benign prostatic hyperplasia<br> (no hospitalization 3 months prior to start of treatment).<br><br>Exclusion Criteria:<br><br> - <br><br> 1. Patients with bladder or prostate malignancy. 2. A history of lower urinary<br> tract surgery. 3. History of catheterization. 4. Urinary retention. 5. Urinary<br> tract infection. 6. Stone disease. 7. Any neurological disease.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluation of International prostate symptom score (IPSS)/quality of life (QoL).;Evaluation of International index of erectile function (IIEF).
- Secondary Outcome Measures
Name Time Method